Erste Group analyst Hans Engel upgraded Johnson & Johnson to Buy from Hold. The firm, which notes that J&J has a higher operating margin and return on equity than its competitors, expects the stock price to rise further in the medium term given the company’s improved growth prospects.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Pacira collabs with J&J’s MedTech to expand market reach of ZILRETTA
- Johnson & Johnson Reports Strong Earnings Growth
- Johnson & Johnson Stock (JNJ) Bulls Target Breakout Despite Looming Patent Cliff
- Johnson & Johnson’s Earnings Call Highlights Growth and Challenges
- Roth MKM medical technology analyst holds analyst/industry conference call